Richard Dugan
Directeur/Bestuurslid bij VANDA PHARMACEUTICALS INC.
Vermogen: 529 666 $ op 30-04-2024
Profiel
Richard W.
Dugan is currently the Lead Independent Director at Vanda Pharmaceuticals, Inc. He previously held positions as Director at Middlebrook Pharmaceuticals, Inc. from 2003 to 2010, Director at Critical Therapeutics, Inc. from 2004 to 2008, and Director at Antisoma, Inc. He also served as Senior Partner at Ernst & Young LLP from 2001 to 2002.
Mr. Dugan obtained his undergraduate degree from The Pennsylvania State University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
17-05-2024 | 118 229 ( 0.21% ) | 529 666 $ | 30-04-2024 |
Actieve functies van Richard Dugan
Bedrijven | Functie | Begin |
---|---|---|
VANDA PHARMACEUTICALS INC. | Directeur/Bestuurslid | 01-12-2005 |
Eerdere bekende functies van Richard Dugan
Bedrijven | Functie | Einde |
---|---|---|
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MiddleBrook Pharmaceuticals, Inc. develops and commercializes anti-infective drug products. It operates mainly in prescription pharmaceuticals. MiddleBrook's main product is PULSYS. PULSYS technology offers the prolonged release and absorption of a drug. The company was incorporated in December 1999 and is headquartered in Westlake, TX. | Directeur/Bestuurslid | 03-08-2010 |
Critical Therapeutics, Inc. | Directeur/Bestuurslid | 04-11-2008 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01-09-2002 |
Antisoma, Inc.
Antisoma, Inc. Pharmaceuticals: MajorHealth Technology Antisoma, Inc. develops drugs and pharmaceuticals. The firm's products include Xanafide, Symadex, and Clomet. Its products are used in clinical and preclinical development for multiple cancer indications. The company was founded in 2001 and is headquartered Cambridge, MA. | Directeur/Bestuurslid | - |
Opleiding van Richard Dugan
The Pennsylvania State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
VANDA PHARMACEUTICALS INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Critical Therapeutics, Inc. | Health Technology |
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MiddleBrook Pharmaceuticals, Inc. develops and commercializes anti-infective drug products. It operates mainly in prescription pharmaceuticals. MiddleBrook's main product is PULSYS. PULSYS technology offers the prolonged release and absorption of a drug. The company was incorporated in December 1999 and is headquartered in Westlake, TX. | Health Technology |
Antisoma, Inc.
Antisoma, Inc. Pharmaceuticals: MajorHealth Technology Antisoma, Inc. develops drugs and pharmaceuticals. The firm's products include Xanafide, Symadex, and Clomet. Its products are used in clinical and preclinical development for multiple cancer indications. The company was founded in 2001 and is headquartered Cambridge, MA. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |